DKK1 and osteoporosis: The goal of this study was to assess the plasma level of sclerostin and DKK-1 in patients with GD and correlate it with the degree of bone involvement, including bone pain, bone marrow infiltration, Erlenmeyer (EM) flask deformity, and osteoporosis.